Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
Search results for: Total knee replacement
ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
Drug Updates
Information on new approvals and medication safety.
Basics of Biologic Joint Reconstruction
For young patients especially, this can delay knee replacement and provide better outcomes.
The Mystery of IVIg
Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.
First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More
“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
A Celebration of Accomplishments
ARHP recognizes health professionals for their contributions to the field
What You Need to Know about ACOs
Rheumatologists may need to speak up to get a place in these new healthcare groups
Drug Updates
Information on new approvals and medication safety
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- Next Page »